Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases
Cytokines and cytokine receptors remain an area of great interest for the development of targeted therapies for cutaneous inflammatory diseases. Anti-TNF therapeutics have proven to be effective in the treatment of psoriasis, and clinical investigations have now begun for other cytokine-directed the...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2006.
|
| Σειρά: | Ernst Schering Research Foundation Workshop,
56 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Inhibition of IFN-? as a Method of Treatment of Various Autoimmune Diseases, Including Skin Diseases
- Cytokine Targeting in Psoriasis and Psoriatic Arthritis: Beyond TNF?
- Inhibitors of Histone Deacetylases as Anti-inflammatory Drugs
- Dendritic Cell Interactions and Cytokine Production
- Lysosomal Cysteine Proteases and Antigen Presentation
- DCs and Cytokines Cooperate for the Induction of Tregs
- Induction of Immunity and Inflammation by Interleukin-12 Family Members
- The Role of TNF? and IL-17 in the Development of Excess IL-1 Signaling-Induced Inflammatory Diseases in IL-1 Receptor Antagonist-Deficient Mice
- TGF?-Mediated Immunoregulation
- TNF Blockade: An Inflammatory Issue
- IL-1 Family Members in Inflammatory Skin Disease
- Regulatory T Cells in Psoriasis.
